Jiating Zhang - Search Results

Year	Number of Results
2002	4
2003	3
2004	4
2005	5
2006	5
2007	8
2008	2
2009	5
2010	8
2011	8
2012	3
2013	6
2014	5
2015	5
2016	6
2017	7
2018	8
2019	5
2020	12
2021	11
2022	6
2023	11
2024	7

1

Smart exosomes enhance PDAC targeted therapy.

Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, Nemunaitis J, Liu JY, Kalinoski A, Rao D, Liu SH. Creeden JF, et al. J Control Release. 2024 Apr;368:413-429. doi: 10.1016/j.jconrel.2024.02.037. Epub 2024 Mar 7. J Control Release. 2024. PMID: 38431093 Free article.

2

Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities.

Gurung D, Danielson JA, Tasnim A, Zhang JT, Zou Y, Liu JY. Gurung D, et al. Biology (Basel). 2023 Jul 14;12(7):1008. doi: 10.3390/biology12071008. Biology (Basel). 2023. PMID: 37508437 Free PMC article. Review.

3

eIF3d: A driver of noncanonical cap-dependent translation of specific mRNAs and a trigger of biological/pathological processes.

Ma S, Liu JY, Zhang JT. Ma S, et al. J Biol Chem. 2023 May;299(5):104658. doi: 10.1016/j.jbc.2023.104658. Epub 2023 Mar 29. J Biol Chem. 2023. PMID: 36997088 Free PMC article. Review.

4

Recent Advances in Fabrication of Well-Organized Protein-Based Nanostructures.

Zhang JT, Ma J, Kankala RK, Yu Q, Wang SB, Chen AZ. Zhang JT, et al. ACS Appl Bio Mater. 2021 May 17;4(5):4039-4048. doi: 10.1021/acsabm.1c00156. Epub 2021 Apr 13. ACS Appl Bio Mater. 2021. PMID: 35006821 Review.

5

Targeting survivin for therapeutic discovery: past, present, and future promises.

Peery RC, Liu JY, Zhang JT. Peery RC, et al. Drug Discov Today. 2017 Oct;22(10):1466-1477. doi: 10.1016/j.drudis.2017.05.009. Epub 2017 May 31. Drug Discov Today. 2017. PMID: 28577912 Free article. Review.

6

Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation.

Qin L, Dong Z, Huang C, Liu H, Beebe J, Subramaniyan B, Hao Y, Liu Y, He Z, Liu JY, Zhang JT. Qin L, et al. Cancer Lett. 2023 Jul 28;567:216266. doi: 10.1016/j.canlet.2023.216266. Epub 2023 Jun 14. Cancer Lett. 2023. PMID: 37321532

7

Self-propelling micro-/nano-motors: Mechanisms, applications, and challenges in drug delivery.

Zhang J, Chen Z, Kankala RK, Wang SB, Chen AZ. Zhang J, et al. Int J Pharm. 2021 Mar 1;596:120275. doi: 10.1016/j.ijpharm.2021.120275. Epub 2021 Jan 26. Int J Pharm. 2021. PMID: 33508344 Review.

8

eIF3a: A new anticancer drug target in the eIF family.

Yin JY, Zhang JT, Zhang W, Zhou HH, Liu ZQ. Yin JY, et al. Cancer Lett. 2018 Jan 1;412:81-87. doi: 10.1016/j.canlet.2017.09.055. Epub 2017 Oct 12. Cancer Lett. 2018. PMID: 29031564 Review.

9

Dimethyl 2,6-dihydroxy-benzene-1,4-dicarboxyl-ate.

Zhao D, Wang K, Zhang J, Jin N. Zhao D, et al. Among authors: zhang j. Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 31;66(Pt 4):o981. doi: 10.1107/S1600536810011074. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21580778 Free PMC article.

10

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis.

Ma S, Dong Z, Cui Q, Liu JY, Zhang JT. Ma S, et al. Cancer Lett. 2021 Mar 1;500:11-20. doi: 10.1016/j.canlet.2020.12.009. Epub 2020 Dec 8. Cancer Lett. 2021. PMID: 33301799 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year